๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Newer aspects of antiarrhythmic drug development: Introduction

โœ Scribed by Mitchell I. Steinberg; Peter Cervoni

Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
243 KB
Volume
19
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Better antiarrhythmics? Development of a
Better antiarrhythmics? Development of antiarrhythmic drugs selective for ischaemia-dependent arrhythmias
โœ Allen I. Bain; Terrance D. Barrett; Gregory N. Beatch; David Fedida; Eric S. Hay ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 287 KB

RSD1000 is one example of a series of compounds synthesized by Nortran Pharmaceuticals, Inc., to provide selective protection against arrhythmias due to myocardial ischaemia and so providing better therapeutic indices than existing drugs. RSD1019 is an analogue of RSD1000, whose therapeutic indices

Role of drug metabolism in drug research
Role of drug metabolism in drug research and development: Pharmaceutical chemistry aspects
โœ Kenneth R. Helmlich ๐Ÿ“‚ Article ๐Ÿ“… 1972 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 377 KB ๐Ÿ‘ 1 views

Pharmacokinetic data obtained jointly by the drug metabolism group and the pharmaceutical chemist are essential to the selection of the proper dosage form for preclinical and Phase I studies. Subsequent biopharmaceutic studies aid in the development of alternate dosage forms and in devising suitable